Cellid
Chemicals & Related Products · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Seoul, Seoul-t'ukpyolsi, South KoreaPhone Number
+82 232857860Website
www.cellid.co.krRevenue
$18 MillionIndustry
About Cellid
CELLID recently finished the administration of subjects in Part C (Phase I) trial of its AdCLD-CoV19-1 COVID-19 vaccine, and shall submit IND for the next stage of clinical trials to the Ministry of Food and Drug Safety, Republic of Korea during Oct. 2021 and has plans to submit interim report of Global clinical trials & EUL on 1 st & 2 nd quarter next year each. CELLID is committed to achieving equitable access to its vaccine, so subject to positive clinical trial results and EUL, CELLID hopes to supply its COVID-19 vaccine through COVAX in the future.Explore more
SIC Code 28,283NAICS Code 32,325Show more
Cellid Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Cellid Tech Stack
A closer look at the technologies used by Cellid
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellid
Sign Up For FreeTo access detailed company insights
CELLID recently finished the administration of subjects in Part C (Phase I) trial of its AdCLD-CoV19-1 COVID-19 vaccine, and shall submit IND for the next stage of clinical trials to the Ministry of Food and Drug Safety, Republic of Korea during Oct. 2021 and has plans to submit interim report of Global clinical trials & EUL on 1 st & 2 nd quarter... Read More
